Skip to main content

Some of the Best-known Metabiotics on the Market of Microecological Products

  • Chapter
  • First Online:
METABIOTICS

Abstract

In the last decade, some metabiotics have been launched on the markets of a number of countries including the Russian Federation, whose production includes natural (or artificial) bioactive molecules similar or identical to those formed by the representatives of normal human microbiota. They have proven their therapeutic and prophylactic efficiency in some infectious and metabolic diseases (Table 1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 189.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  • Aguilar-Toaláa JE, Garcia-Varela R, Garcia HS, Mata-Harod V, González-Córdovaa AF et al. Postbiotics: An evolving term within the functional foods field. Trends in Food Science & Technology. 2018;75:105–114. doi:https://doi.org/10.1016/j.tifs.2018.03.009.

    Article  CAS  Google Scholar 

  • Beider C, Flambard B. Dairy for heart health. World Food Ingredients. 2003:24–26.

    Google Scholar 

  • Belousova EF, Nikitina YuI, Mishurovskaya N, Zlatkina AR. Possibilities of microbial metabolites in the recovery of intestinal microbiota. Consilium Medicum. 2005;7:9–13 (in Russian).

    Google Scholar 

  • Caselli M, Vaira G, Calo G, Papini F, Holton J, Vaira D. Structural bacterial molecules as potential candidates for an evolution of the classical concept of probiotics. Adv Nutr. 2011;2:372–376. doi:https://doi.org/10.3945/an.111.000604.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hunt RH, Xiao SD, Megraud F, Leon-Barua R, Bazzoli F et al. Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline. J Gastrointestin Liver Dis. 2011;20(3):299–304.

    CAS  PubMed  Google Scholar 

  • Klein G, Schanstra JP, Hoffmann J, Mischak H, Siwy J, Zimmerman K. Proteomics as a quality control tool of pharmaceutical probiotic bacterial lysate products. PLoS One. 2013;8(6):e66682. doi:https://doi.org/10.1371/journal.pone.0066682.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kocharovec VI. Hilak Forte: modern model metabiotics with biotherapeutic activity. Moscow: Prime-Media; 2018 (in Russian).

    Google Scholar 

  • Lakhtin V, Lakhtin MV, Pospelova VV, Shenderov BA. Lectins of lactobacilli and bifidobacteria. II Probiotic lectins of lactobacilli and bifidobacteria as possible signal molecules regulating inter- and intrapopulation relationships between bacteria and between bacteria and the host. Microb Ecol Health Dis. 2007;19(3):153–157. doi:https://doi.org/10.1080/08910600701538257.

    Article  CAS  Google Scholar 

  • Lakhtin VM, Lakhtin MV, Cherepanova YuV, Pospelova VV, Afanasyev SS, Aleshkin VA. High molecular weight biosurfactants of human gram-positive bacteria. Clin lab diagn. 2010;9:37–38 (in Russian).

    Google Scholar 

  • Lebeer S, Vanderleyden J, De Keersmaeker SCJ. Genes and molecules of lactobacilli supporting probiotic action. Microbiol Mol Biol Rev. 2008;72(4):728–764. doi:https://doi.org/10.1128/MMBR.00017-08.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lebeer S, Vanderleyden J, De Keersmaeker SCJ. Host interactions of probiotic bacterial surface molecules: cоmparison with commensals and pathogens. Natl Rev Microbiol. 2010; 8(3):171–184. doi:https://doi.org/10.1038/nrmicro2297.

    Article  CAS  Google Scholar 

  • Nakamura Y, Bando I, Mennear JY, Bernard BK. Studies of toxicological potential of tripeptides. IV. Assessment of the repeated-dose toxicological potential of synthesized L-valyl-L-prolyl-L-proline in male and female rats and dogs. Int J Toxicol. 2005;24:25–39.

    Article  CAS  PubMed  Google Scholar 

  • Nakamura Y. Studies on anti-hypertensive peptides in milk fermented with Lactobacillus helveticus. Biosci Microflora. 2004;23:131–138. doi:https://doi.org/10.12938/bifidus.23.131.

    Article  CAS  Google Scholar 

  • Popova TS, Zhuravel SV, Chernenkaya TV, Tropskaya NS. Preclinical and clinical evaluation of the effectiveness of the product for functional nutrition «Extract of lactic acid bacteria fermented in soy milk «Daigo». Moscow: Daigo; 2016 (in Russian).

    Google Scholar 

  • Rudkowski Z, Bromirska J. Shortening of the period of fecal excretion of salmonella in infants under treatment with Hylak forte. Paediatrie und Paedologie. 1991; 26(2):111–114. https://eurekamag.com/research/007/790/007790996.php. .

    CAS  Google Scholar 

  • Sawada H, Furushiro M, Hirai K, Motoike M, Watanabe T, Yokokura T. Purification and characterization of an antihypertensive compound from Lactobacillus casei. Agric Biol Chem. 1990;54:3211–3219.

    CAS  PubMed  Google Scholar 

  • Shenderov BA, Ivanova YaV, Sorokina IM. Complex food product enrichment. PATENT RF 2397246. 2010 (in Russian).

    Google Scholar 

  • Shenderov BA, Lakhtin MV. Lectins as a new potential category of physiologically active functional food ingredients. Journal of Restorative Medicine & Rehabilitation. 2004;1:33–38 (in Russian).

    Google Scholar 

  • Singh A, Vishwakarma V, Singhal B. Metabiotics: The Functional Metabolic Signatures of Probiotics: Current State-of-Art and Future Research Priorities — Metabiotics: Probiotics Effector Molecules. Advan Biosci Biotechnol. 2018;9(4):147–189. doi:https://doi.org/10.4236/abb.2018.94012.

    Article  CAS  Google Scholar 

  • Sobol CV, Sobol YT. Composition and method to produce and use fermented hydrolyzed products of microbial metabolism. Canada Patent 2484639. 2012.

    Google Scholar 

  • Sobol CV. A new class of Pharmabiotics with Unique Properties. Chapter 4. In: Grumezescu AM, Holban AM, editors. Handbook of Food Bioengineering. Vol. 3. Soft Chemistry and Food Fermentation. London: Elsevier Inc.; 2017. p. 79–108. doi:https://doi.org/10.1016/B978-0-12-811412-4.00004-7.

    Chapter  Google Scholar 

  • Sonnenburg JL, Backhed F. Diet-microbiota interactions as moderators of human metabolism. Nature. 2016;535(7610):56–64. doi:https://doi.org/10.1038/nature18846.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Tsuda T, Tsuda M, Yamamura V, Ohnishi N. Regulation of appetite and gastrointestinal microflora. J Germfree Life Gnotobiol. 1992;22:23–25.

    Google Scholar 

  • Zihler A, Le Blay G, de Wouters T, Lacroix C, Braegger CP et al. In vitro inhibition activity of defferent bacteriocin-producing Escherichia coli against Salmonella strains isolated from clinical cases. Letters in Applied Microbiology. 2009;49(1):31–38. doi:https://doi.org/10.1111/j.1472-765X.2009.02614.x.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Shenderov, B.A., Sinitsa, A.V., Zakharchenko, M.M., Lang, C. (2020). Some of the Best-known Metabiotics on the Market of Microecological Products. In: METABIOTICS. Springer, Cham. https://doi.org/10.1007/978-3-030-34167-1_13

Download citation

Publish with us

Policies and ethics